Our findings are consistent with previous research, that high IRF9, PLA2G4A, MLKL, BAX, JAK2, and STAT3 expression in MDS compared to health controls and is associated with poor prognosis. This evidence concerns the gene PLA2G4A and myelodysplastic syndrome.